ASTCT Talks
MRD Negativity and Lenalidomide Maintenance Therapy: The Possible Next Chapter in Multiple Myeloma Care
02 Dec 2020
On this episode of ASTCT Talks, we sit down with Dilan Patel, MD, advanced BMT fellow at Washington University School of Medicine in St. Louis. Patel was the lead author on a paper that explored minimal residual disease negativity and lenalidomide maintenance therapy, and how those were associated with superior survival outcomes for patients with multiple myeloma.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
TNB Tech Minute: FTC Orders Instacart to Pay $60 Million Over Deceptive Practices
18 Dec 2025
WSJ Tech News Briefing
Hidden Gem Stocks We Love at the End of the Year
18 Dec 2025
Motley Fool Money
Google Undercuts the Field, OpenAI Builds an App OS, and China Accelerates
18 Dec 2025
The Daily AI Show
Lucy Liu
18 Dec 2025
Fresh Air
#2428 - Michael P. Masters
18 Dec 2025
The Joe Rogan Experience